Adamis pharmaceuticals participated in white house meeting regarding opioid overdose prevention

San diego, june 22, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company, today announced that eboo versi, md, phd, ceo of adamis pharmaceuticals is proud and excited to have participated in the white house roundtable with opioid reversal product manufacturers, hosted by white house office of national drug control policy director, dr. rahul gupta, white house domestic policy council advisor neera tanden, u.s. assistant secretary for health admiral rachel levine, and u.s. assistant secretary for mental health and substance use dr. miriam e. delphin-rittmon. dr. gupta is the first medical doctor to ever lead the white house office of national drug control policy (ondcp). ondcp is responsible for the development and implementation of the national drug control strategy and budget. the roundtable discussion was held on june 20, 2023.
ADMP Ratings Summary
ADMP Quant Ranking